Related Experiment Video
Updated: Jul 29, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Factors associated with medication adherence among children with rheumatic diseases
Roongroj Manatpreeprem1, Butsabong Lerkvaleekul1, Soamarat Vilaiyuk1
1Rheumatology Division, Pediatric Department, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Insights
Poor medication adherence affects one-fourth of pediatric rheumatic disease patients. Key factors include forgetfulness and lack of awareness regarding treatment importance, impacting health outcomes.
Area of Science:
- Pediatric Rheumatology
- Adherence Research
- Chronic Disease Management
Background:
- Medication non-adherence significantly worsens health outcomes in pediatric rheumatic diseases.
- The Pediatric Rheumatology Adherence Questionnaire (PRAQ) is a validated tool for assessing adherence.
- Understanding factors associated with poor adherence is crucial for improving patient care.
Purpose of the Study:
- To identify factors associated with poor medication adherence in children with rheumatic diseases.
- To validate the Thai version of the PRAQ in this patient population.
- To determine the prevalence of poor medication adherence in pediatric rheumatology patients.
Main Methods:
- Cross-sectional study involving pediatric rheumatology patients and their caregivers.
- Medication adherence assessed using the pill count method (adherence <80% defined as poor).
- Thai version of the PRAQ administered; additional interviews conducted to identify adherence barriers.
Main Results:
- Poor adherence was observed in approximately 25% of patients.
- Enthesitis-related arthritis (ERA) and polyarticular juvenile idiopathic arthritis (JIA) were associated with higher rates of non-adherence.
- Key predictors of poor adherence included longer disease duration (≥5 years), active disease, high PRAQ scores, forgetfulness, and lack of awareness regarding medication importance.
Conclusions:
- One-fourth of children with rheumatic diseases exhibit poor medication adherence.
- Specific diagnoses (ERA, polyarticular JIA), disease characteristics (longer duration, active disease), and higher PRAQ scores are linked to non-adherence.
- Forgetfulness and lack of understanding about treatment necessity are primary barriers to consistent medication use.
Abstract:
Introduction: Failure to take medications regularly leads to poorer health outcomes. The Pediatric Rheumatology Adherence Questionnaire (PRAQ) is an effective tool for assessing medication adherence in rheumatic patients. Therefore, we aimed to determine the factors associated with poor medication adherence among children with rheumatic diseases. Methods: This was a cross-sectional study. Patients with rheumatic diseases who had taken at least one medication and had been followed up at our pediatric rheumatology clinic were included in the study, together with their caregivers. Patients with poor medication adherence were characterized as those who had taken less than 80% of their prescribed drugs, as determined using the pill count method. The original PRAQ was translated and validated in Thai language and was completed by caregivers and literate patients over age 13 years. Interviewing for additional problems with taking medications was conducted. We performed descriptive and logistic regression analyses. Results: From 210 patients, 52.86% had juvenile idiopathic arthritis (JIA), and 46.19% had connective tissue diseases. The mean patient age was 14.10 ± 4.74 years, with a median (interquartile range) disease duration of 4.33 (2.08-6.98) years. PRAQ scores in the group with poor adherence were significantly higher than scores in the group with good adherence (11.00 ± 3.47 vs. 9.51 ± 3.16, p = 0.004). Enthesitis-related arthritis (ERA) (odds ratio [OR] 9.09, 95% confidence interval [CI] 1.25-66.18; p = 0.029) and polyarticular JIA (OR 6.43, 95% CI 1.30-31.75; p = 0.022) were associated with poor treatment adherence. Disease duration ≥5 years (OR 3.88, 95% CI 1.17-12.87; p = 0.027), active disease (OR 6.49, 95% CI 1.76-23.99; p = 0.005), PRAQ scores ≥12 (OR 6.48, 95% CI 1.76-23.82; p = 0.005), forgetting to take medications (OR 14.18, 95% CI 4.21-47.73; p < 0.001), and unawareness about the importance of the medicines (OR 44.18, 95% CI 11.30-172.73; p < 0.001) were predictors of poor drug adherence. Conclusion: In the present study, poor medication adherence was found in one-fourth of children with rheumatic illnesses, particularly those with ERA, polyarticular JIA, longer disease duration, active disease, and high PRAQ scores. The most frequent reasons for inadequate medication adherence were forgetfulness and unawareness about the importance of disease control and consistency with treatment.
More Related Videos
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management
Drug Therapy
Antianxiety Medications
Factors Affecting Drug Response: Overview
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

